X. Gao et al., EXTENSIVE ABSORPTION OF 2',3'-DIDEOXYINOSINE BY INTRATRACHEAL ADMINISTRATION IN RATS, Pharmaceutical research, 12(12), 1995, pp. 1901-1906
Purpose. To evaluate the intratracheal route of administration as an a
lternative to oral administration for 2',3'-dideoxyinosine (ddI). Meth
ods. A ddI dose (40 mg/kg/300 mu l or 6.5 mg/kg/50 mu l) was instilled
into the trachea in female Fisher rats and an intravenous tracer dose
(9 mu g/kg) of H-1-ddI was administered concomitantly to determine th
e drug clearance. Plasma concentrations were analyzed for the rate and
extent of absorption. Results. ddI was rapidly absorbed from the lung
s, with a bioavailability of 63% at 40 mg/kg and 101% at 6.5 mg/kg. By
comparison, our previous data showed an oral bioavailability of about
15% (Pharm Res., 9:822, 1992). The distribution of a dye solution ins
tilled intratracheally showed that a fraction of the 300 mu l dose spi
lled over to the gastrointestinal tract, where the entire 50 mu l dose
was retained in the lungs. The different distribution of the two dose
s/volumes likely contributed to the different bioavailability, with a
fraction of the higher dose/volume degraded in the gastrointestinal tr
act after the spillover. Absorption of ddI from the airspace of the lu
ng was biexponential, suggesting two absorption processes. Conclusions
. These data indicate significantly higher and less variable bioavaila
bility of ddI by the intratracheal route of delivery compared to the o
ral route. Furthermore, the complete bioavailability at the lower dose
/volume indicates no significant pulmonary first pass elimination for
ddI.